Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of ToleroMune Ragweed in ragweed allergy
NCT00878774Phase 2Completed
- Sponsor
- NIOX Group
- Start
- Apr 2009
- Primary completion
- Nov 2009
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ragweed-spire in ragweed allergy, sponsored by NIOX Group. Started Apr 2009; status: completed.
02
Drugs
ragweed-spire
03
Conditions
ragweed allergy
Beyond the preview
Go deeper on NCT00878774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00878774.